ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TYRA Tyra Biosciences Inc

17.325
0.125 (0.73%)
Last Updated: 08:52:52
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,627
Bid Price 17.04
Ask Price 17.48
News -
Day High 17.325

Low
10.38

52 Week Range

High
21.14

Day Low 17.05
Share Name Share Symbol Market Stock Type
Tyra Biosciences Inc TYRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.125 0.73% 17.325 08:52:52
Open Price Low Price High Price Close Price Previous Close
17.11 17.05 17.325 17.20
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
71 2,627 US$ 17.11 US$ 44,935 - 10.38 - 21.14
Last Trade Type Quantity Price Currency
08:52:52 10 US$ 17.29 USD

Tyra Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
740.61M 43.06M - 0 -69.13M -1.61 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Tyra Biosciences News

Date Time Source News Article
6/10/202418:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202414:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/31/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/31/202415:02Edgar (US Regulatory)Form 8-K - Current report
5/23/202415:05PR Newswire (US)Tyra Biosciences to Present at Upcoming Investor Conferences
5/09/202415:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/09/202415:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202415:08Edgar (US Regulatory)Form 8-K - Current report
5/09/202415:05PR Newswire (US)Tyra Biosciences Reports First Quarter 2024 Financial..
5/07/202415:34Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
5/07/202415:29Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TYRA Message Board. Create One! See More Posts on TYRA Message Board See More Message Board Posts

Historical TYRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.0120.1517.0518.60106,049-1.69-8.86%
1 Month17.6521.1415.3218.28152,336-0.325-1.84%
3 Months16.3421.1414.1217.44135,2860.9856.03%
6 Months14.2421.1411.2416.88134,9933.0921.66%
1 Year16.6621.1410.3816.03101,6280.6653.99%
3 Years29.9031.364.9314.88102,359-12.58-42.06%
5 Years29.9031.364.9314.88102,359-12.58-42.06%

Tyra Biosciences Description

Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.